Oximio works hard to convert the ever-changing face of investigational medical products into new medicines, bringing over 16 years of service excellence to the clinical trial industry. The company provides a direct connection to several patient communities of over 500 million people by being present in the United Kingdom, Eastern Europe, Western Asia, and South Africa.
Oximio has a large and loyal client base ranging from start-ups to major international organizations involved in pharmaceuticals and R&D. Oximio is in the front line of servicing clinical trials with own warehouses and through licensed partner sites, offering an end-to-end cold-chain control system in all of its premises.
By combining its’ ‘best-in-class’ depot network with a highly experienced and qualified workforce, Oximio is thoroughly conversant with both global and local procedures for clinical trials, ensuring the highest standards of operation.